10 Best Affordable Stocks to Buy According to Wall Street Analysts

7. Koninklijke Philips N.V. (NYSE:PHG)

On May 6, 2026, Koninklijke Philips N.V. (NYSE:PHG) reported Q1 adjusted EPS of EUR 0.23 compared to EUR 0.25 last year. Revenue totaled EUR 3.91B compared to EUR 4.1B in the prior-year period. The company said it delivered a solid start to 2026, with order intake growth of 6%, comparable sales growth of 4%, and adjusted EBITDA margin expansion of 40 basis points, supported by disciplined execution despite an uncertain macroeconomic backdrop. Philips added that sales growth was driven by North America and Europe and spanned all operating segments.

The company also said it is advancing a new strategy focused on accelerating profitable growth through segment-specific priorities, platform-based innovation, and operational discipline. Philips highlighted several AI-related developments during the quarter, including regulatory approval for SmartHeart, which automates cardiac MRI planning, and DeviceGuide, which adds AI-powered real-time guidance to cardiac procedures on the Azurion platform. Philips also pointed to continued demand for its OneBlade grooming platform.

Koninklijke Philips N.V. (NYSE:PHG) maintained its FY26 outlook for comparable sales growth of 3%-4.5%, adjusted EBITDA margin of 12.5%-13%, and free cash flow of EUR 1.3 B-EUR 1.5 B. The company said its outlook incorporates currently known tariff impacts and broader macroeconomic uncertainty but excludes any potential International Emergency Economic Powers Act tariff refunds and ongoing Philips Respironics-related legal proceedings.

Last month, Koninklijke Philips N.V. (NYSE:PHG) announced it received FDA 510(k) clearance for its Rembra imaging platform, including the Rembra CT, Rembra RT, and Areta RT systems. The company said the systems are designed to help healthcare providers improve imaging and radiation therapy planning efficiency as demand and clinical complexity continue to increase.

Koninklijke Philips N.V. (NYSE:PHG) operates as a health technology company serving markets across North America, Greater China, and internationally.